Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing ...

In just a few months, Novo AI's advanced solution has elevated APRIL International's performance across Thailand, Vietnam, ...

Abstract Title: A single-arm, multicenter, Phase 2 study of hepatic arterial infusion chemotherapy (HAIC) combined with ...

Throughout its 28 years of operation, Masan Group has emerged as a key player in Vietnam’s dealmaking landscape, leveraging ...

Vietnam’s food and beverage market remains a fertile land for investors to step up merger and acquisition activities, with a ...

A partnership with international groups to implement The One World urban area project marks an important milestone in Kim ...

Vietnam in 2024 has witnessed cautious investor sentiment when it comes to big deals, but key traditional sectors continued ...

Vietnam is increasingly vulnerable to economic losses from climate-driven disasters, underscoring the urgent need for ...

Environmental, social, and governance practices are an opportunity to build new competitive advantages for Vietnamese lenders ...

Expansionary fiscal policy and loose monetary policy remain the mainstays of macroeconomic policies, given the current low ...

Today, banks in the US and Europe are pioneers in integrating environmental, social, and governance (ESG) into business ...

Global biopharmaceutical company Takeda is deepening collaboration with stakeholders to deliver innovative healthcare ...